After a preliminary analysis of long-term follow-up data, the FDA has found that paclitaxel-coated devices used to treat femoropopliteal artery disease are linked with up to approximately a 50% increased risk in mortality. | Read More

The Vascular Leaders forum 2019 featured experts who addressed questions raised by the meta-analysis of paclitaxel-eluting devices by Katsanos and colleagues. | Read More

After analyzing data from Centers for Medicare and Medicaid Services beneficiaries, researchers found no evidence of increased all-cause mortality for patients who underwent femoropopliteal artery revascularization with drug-coated devices compared… | Read More

To further establish whether such an association exists, and to what extent the factors are linked, the researchers used data from several population-based cohort studies spanning decades, according to a study published in JAMA Cardiology. | Read More

Eximo Medical Ltd., announced the successful launch and first commercial use of the B-Laser™ Atherectomy System for treatment of peripheral vascular disease. | Read More

Thoracic endovascular aortic repair (TEVAR) is associated with a greater survival benefit vs medical therapy in patients with uncomplicated type B aortic dissection (UTBAD), according to a new study. | Read More

CERENOVUS business has launched the single largest global registry, the EXCELLENT Registry, to collect and analyze stroke-inducing blood clots removed from the brain with its EMBOTRAP II Revascularization Device, a next generation stent retriever… | Read More

Becton, Dickinson and Company presented safety and efficacy results of the LUTONIX® trial during a late-breaking clinical trials session at VIVA 2018. | Read More

Global position statement from the Society of Interventional Radiology (SIR), Cardiovascular and Interventional Radiology Society of Europe (CIRSE), and the Interventional Radiology Society of Australasia (IRSA) highlights critical needs on World… | Read More